OrthoLazer Orthopedic Laser Centers Secures $3.5 Million in Funding for Nationwide Expansion

OrthoLazer Orthopedic Laser Centers is thrilled to announce a significant funding milestone, having successfully raised $3.5 million to expand its innovative pain management solutions across the country. Founded by Dr. Scott Sigman, an esteemed pioneer in opioid-sparing surgical practices, OrthoLazer aims to transform the treatment landscape for individuals suffering from acute and chronic orthopedic conditions. With an increasing number of patients seeking alternatives to traditional pain management methods, the overwhelming response to the inaugural OrthoLazer Center has sparked the initiative to broaden access to its cutting-edge services nationwide. The company’s state-of-the-art MLS M8 Robotic Laser technology offers a non-invasive and painless solution, effectively targeting pain and inflammation linked to soft tissue injuries, nerve pain, arthritis, and postoperative recovery. Distinguished by its FDA clearance and patented design, the MLS M8 stands out as the only high-powered laser offering a safe, side-effect-free alternative to conventional therapies. This funding will allow OrthoLazer to enhance its facilities, increase patient outreach, and establish new centers across multiple regions, making its non-opioid treatment options available to a wider audience. This strategic expansion is not only a testament to the growing demand for innovative healthcare solutions, but also aligns with Dr. Sigman’s unwavering commitment to patient welfare and pain management education. As OrthoLazer looks ahead, it is excited to lead the charge in modernizing orthopedic care, offering patients a brighter future free from the limitations of traditional pain management approaches.